Literature DB >> 8325336

Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen.

B A Hart1, N P Bakker, M Jonker, R E Bontrop.   

Abstract

Immunization of susceptible rodent or primate species with type II collagen (b-CII) from bovine origin induces type II collagen-induced arthritis (CIA). The disease is characterized as a systemic polyarthritis associated with humoral and cellular autoimmunity to CII and shares similarity with human arthritic diseases. The objective of this study was to develop a procedure for induction of resistance to CIA in animals, which possess a certain major histocompatibility complex phenotype that makes them prone to develop CIA (susceptible). It is shown that by immunization with an attenuated form of CII, in which arthritogenic epitopes have been destroyed by heat denaturation, disease resistance is induced in a susceptible inbred rat strain (RT-1u) and in an outbred population of susceptible rhesus monkeys (lacking the Mamu-A26 allele). In both species the disease resistance is connected with modulation of anti-CII autoantibodies of the IgM isotype. This protocol may provide a basis for effective and safe methods to induce protection to autoimmune arthritis in those subjects that are genetically prone to develop such a disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325336     DOI: 10.1002/eji.1830230729

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys.

Authors:  H P Brok; J M Tekoppele; J Hakimi; J A Kerwin; E M Nijenhuis; C W De Groot; R E Bontrop; B A 't Hart
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Arthritogenicity of collagen type II is increased by chlorination.

Authors:  E Westman; K Lundberg; H Erlandsson Harris
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.

Authors:  S Turner; N P Bakker; B A t Hart; P J Holt; K Morgan
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

4.  3rd International Symposium on the Immunotherapy of the Rheumatic Diseases. 10-14 May 1995, Cyprus. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-09       Impact factor: 19.103

5.  Accelerated onset of collagen-induced arthritis by remote inflammation.

Authors:  L A Joosten; M M Helsen; W B van den Berg
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

6.  The anti-arthritic and immunosuppressive effects of cyclosporin A on collagen-induced arthritis in the rhesus monkey.

Authors:  N P Bakker; N Van Besouw; R Groenestein; M Jonker; L A Hart
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  Therapeutic effects of estradiol benzoate on development of collagen-induced arthritis (CIA) in the Lewis rat are mediated via suppression of the humoral response against denatured collagen type II (CII).

Authors:  Y Waksman; I Hod; A Friedman
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

8.  Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis.

Authors:  M P M Vierboom; E Breedveld; Y S Kap; C Mary; N Poirier; B A 't Hart; B Vanhove
Journal:  Clin Exp Immunol       Date:  2015-12-16       Impact factor: 4.330

9.  Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis.

Authors:  Michel P M Vierboom; Elia Breedveld; Ivanela Kondova; Bert A 't Hart
Journal:  Arthritis Res Ther       Date:  2010-10-26       Impact factor: 5.156

Review 10.  Modeling human arthritic diseases in nonhuman primates.

Authors:  Michel P M Vierboom; Margreet Jonker; Ronald E Bontrop; Bert 't Hart
Journal:  Arthritis Res Ther       Date:  2005-06-09       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.